AdvaMed Encourages HHS CER Inventory Efforts; Drug Groups Press For Delay
This article was originally published in The Gray Sheet
Executive Summary
AdvaMed is encouraging Health and Human Services' efforts to start building a centralized inventory of comparative effectiveness research, even as drug industry groups complain the project would be "premature" before a congressionally established public-private institute gets up and running
You may also be interested in...
Inventory Of Comparative Effectiveness Studies Hits The Web
Nearly 500 comparative research projects are listed in a new online inventory launched Nov. 16 by the Partnership to Improve Patient Care.
Inventory Of Comparative Effectiveness Studies Hits The Web
Nearly 500 comparative research projects are listed in a new online inventory launched Nov. 16 by the Partnership to Improve Patient Care.
New Tools Needed To Spread Word On Comparative Research Findings
New tools are needed to ensure patients and doctors can make sense of the increasing volume of comparative effectiveness research expected out in coming years, policy experts suggest in recent papers in Health Affairs.